MASH / NASH
Metabolic dysfunction-associated steatohepatitis (MASH), formerly called nonalcoholic steatohepatitis (NASH), is the inflammatory and fibrotic form of MASLD that can progress to cirrhosis, liver failure, and hepatocellular carcinoma.
Phase 1/2 and later readouts in MASH / NASH, in your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
Coverage in progress. AssetMemo has not yet run its full census for NASH Cirrhosis, so the assets listed for it are not complete.
Combined attributable cost
$32.0B+
Drug spend
Not yet sourced
Sum of 2 indications below.